UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): November 3, 2004

 

Axcelis Technologies, Inc.

(Exact name of registrant as specified in charter)

 

Delaware

000-30941

34-1818596

(State or other jurisdiction of
incorporation)

(Commission File Number)

(IRS Employer Identification No.)

 

 

 

108 Cherry Hill Drive, Beverly, Massachusetts

01915

(Address of principal executive offices)

(Zip Code)

 

Registrant’s telephone number, including area code: (978) 787-4000

 

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

o    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 



 

Item 2.02    Results of Operations and Financial Condition.

 

On November 3, 2004, Axcelis Technologies, Inc. (the “Company”) issued a press release regarding its financial results for the quarter ended September 30, 2004. The Company’s press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and incorporated by reference herein.

 

The information in this Current Report on Form 8-K and the Exhibit attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, regardless of any general incorporation language in such filing.

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: November 3, 2004

Axcelis Technologies, Inc.

 

 

 

 

 

By:

/S/ STEPHEN G. BASSETT

 

 

Stephen G. Bassett
Senior Vice President and Chief Financial Officer

 

2



 

EXHIBIT INDEX

 

Exhibit No.

 

Description

 

 

 

99.1

 

Press release dated November 3, 2004

 

3


Exhibit 99.1

 

FOR IMMEDIATE RELEASE

 

Media Contact:

Investor Contact:

Agency Contact:

Maureen Hart

James L. Kawski

Stacy Grisinger

Axcelis Technologies, Inc.

Axcelis Technologies, Inc.

The Loomis Group Inc.

Tel: (978) 787-4266

Tel: (978) 787-4000

Tel: (617) 638-0022

Fax: (978) 787-4275

Fax: (978) 787-9133

Fax: (617) 638-0033

maureen.hart@axcelis.com

investor.relations@axcelis.com

grisingers@loomisgroup.com

 

AXCELIS ANNOUNCES FINANCIAL RESULTS FOR THE

THIRD QUARTER 2004

 

BEVERLY, MA, November 3, 2004 – Axcelis Technologies, Inc. (Nasdaq: ACLS) today announced financial results for its third quarter ended September 30, 2004.  The Company reported net revenues of $127.9 million, compared to $151.3 million for the second quarter of 2004. Worldwide revenues for the third quarter, including revenues of the Company’s 50% owned joint venture in Japan, Sumitomo Eaton Nova Corporation (“SEN”), were $219 million, essentially flat when compared to the second quarter of 2004. Net income for the quarter was $19.1 million ($0.19 per diluted share) compared to $34.5 million ($0.33 per diluted share) in the second quarter of 2004.  Gross margin for the third quarter was 42.3%.

 

 

Mary Puma, president and Chief Executive Officer stated, “Although business was slower than we had expected in the third quarter, Axcelis continued to deliver strong financial performance at current revenue levels.  During the last two weeks of the third quarter we saw an acceleration of softness in our markets, represented by customer requirements being pushed out to the first half of 2005. Despite this, we continue to see solid growth in Japan through our joint venture partner SEN.”

 

Puma continued, “Our focus throughout any change in the market is managing the business to sustain profitability. We controlled headcount growth during the earlier part of 2004 and are responding to the current environment. We will continue to take actions that will realign our organization with market conditions, without disrupting key product initiatives. Our operating leverage remains strong at our current revenue levels. We are very pleased with the tremendous growth and financial performance Axcelis has delivered this year.”

 

Axcelis believes that the information regarding the aggregate quarterly revenues of SEN, a 50% owned unconsolidated subsidiary of Axcelis, combined with Axcelis’ own revenues for the quarter, is useful to investors.  SEN’s ion implant products are covered by a license from Axcelis and therefore the combined revenue of the two companies indicates the full market penetration of Axcelis’ technology.

 



 

Fourth Quarter Outlook

Net revenues (excluding SEN) in the fourth quarter are expected to decrease to $95 million to $105 million. Gross margins will be in the low 40’s. Net income will be in the range of $5 million to $9 million ($0.05 to $0.09 per diluted share). The Company expects to generate approximately $10 million of cash during the fourth quarter.

 

Third Quarter Detail

 

Shipments

Shipments for the third quarter on a worldwide basis, including SEN, totaled $224.1 million with net shipments, excluding SEN, totaling $129.6 million. Worldwide shipments were down 7.4% from the second quarter of 2004 and net shipments were down 17.2%.

 

Service revenue (service labor, spare parts and consumables) was $44.8 million for the quarter, up 9% from the second quarter of 2004. Geographically, systems shipments were to:  Asia 58%, Europe 26% and North America 16%.

 

The ion implantation business (excluding SEN) accounted for 77.8% of total shipments in the third quarter while the complementary products (RTP, Dry Strip and Curing) accounted for 22.2%.

 

Orders and Backlog

Net orders (systems and service excluding SEN) received for the third quarter totaled $126.3 million, down 22.7% from the second quarter of 2004. System bookings amounted to $81.5 million, down 33.3% from second quarter of 2004. Worldwide orders, including SEN, were $234.3 million, down 6.0% compared with the second quarter of 2004.

 

Geographically, net system orders without SEN were split as follows: Asia 62%, Europe 21% and North America 17%.  Logic manufacturers (integrated device manufacturers and foundries) accounted for 41% of systems orders while memory manufacturers made up 59%.  The book to bill ratio for the quarter was 0.96.

 

Backlog plus deferred systems revenue for the quarter ended at $146.7 million, an increase of 1.0% since the end of the second quarter of 2004. Reported backlog consists of systems only (i.e., excluding service contracts) that are generally scheduled to ship within six months.

 

Balance Sheet

Axcelis ended the third quarter with $167.5 million in cash, cash equivalents and short-term investments compared with $163.7 million at the end of the second quarter of 2004. The Company generated $3.8 million in cash during the quarter.

 

Third Quarter 2004 Conference Call

 

The call will be available to interested listeners via an audio Webcast that can be accessed through Axcelis’ home page at www.axcelis.com, or by dialing 1-800-500-0177 (1-719-457-2679 outside North America).  Participants calling into the conference call will be requested to provide the company name: Axcelis Technologies, the conference leader: Jim Kawski, and pass code: Axcelis

 



 

Q3.  A telephone replay will be available from 8:00 pm EST on November 3, 2004 until 11.59 pm EST on November 10, 2004.  Dial 1-888-203-1112 (1-719-457-0820 outside North America), and enter conference ID code #350309.  A Webcast replay will be available from 8:00 pm EST on November 3, 2004 until 5:00 pm EST December 1, 2004.

 

Safe Harbor Statement

 

This document contains forward-looking statements under the SEC safe harbor provisions.  These statements are based on management’s current expectations and should be viewed with caution. They are subject to various risks and uncertainties, many of which are outside the control of the Company, including the conversion of orders to revenue in any particular quarter, or at all, our ability to implement successfully our profit plans, the continuing demand for semiconductor equipment, relative market growth, continuity of business relationships with and purchases by major customers, competitive pressure on sales and pricing, increases in material and other production costs that cannot be recouped in product pricing and global economic, political and financial conditions. These risks and other risk factors relating to Axcelis are described more fully in the most recent Form 10-K filed by Axcelis and in other documents filed from time to time with the Securities and Exchange Commission.

 

About Axcelis Technologies, Inc.

 

Axcelis Technologies, Inc., headquartered in Beverly, Massachusetts, provides innovative, high-productivity solutions for the semiconductor industry. Axcelis is dedicated to developing enabling process applications through the design, manufacture and complete life cycle support of ion implantation, rapid thermal processing, and cleaning and curing systems. Axcelis Technologies has key technology centers in Beverly, Massachusetts, and Rockville, Maryland as well as in Toyo, Japan through its joint venture, SEN. The company’s Internet address is: www.axcelis.com.

 



 

 

Axcelis Technologies, Inc.

Consolidated Balance Sheets

In thousands

(Unaudited)

 

 

 

September 30,
2004

 

December 31,
2003

 

 

 

 

 

 

 

Assets

 

 

 

 

 

 

 

 

 

 

 

Current assets

 

 

 

 

 

Cash and cash equivalents

 

$

138,004

 

$

93,249

 

Restricted cash

 

3,370

 

3,800

 

Short-term investments

 

23,549

 

14,972

 

Accounts receivable, net

 

110,259

 

73,751

 

Inventories

 

117,619

 

123,985

 

Other current assets

 

20,208

 

20,102

 

Total current assets

 

413,009

 

329,859

 

 

 

 

 

 

 

Property, plant & equipment, net

 

76,163

 

80,927

 

Investment in Sumitomo Eaton Nova Corporation

 

93,628

 

73,327

 

Goodwill

 

46,773

 

46,774

 

Intangible assets

 

18,283

 

20,119

 

Restricted cash, long-term portion

 

2,616

 

2,616

 

Other assets

 

28,470

 

31,973

 

 

 

$

678,942

 

$

585,595

 

 

 

 

 

 

 

Liabilities and stockholders’ equity

 

 

 

 

 

 

 

 

 

 

 

Current liabilities

 

 

 

 

 

Accounts payable

 

$

28,280

 

$

36,335

 

Accrued compensation

 

25,499

 

15,061

 

Warranty

 

14,642

 

17,000

 

Income taxes

 

5,919

 

7,109

 

Deferred revenue

 

28,425

 

14,441

 

Other current liabilities

 

15,977

 

11,925

 

Total current liabilities

 

118,742

 

101,871

 

 

 

 

 

 

 

Long-term debt

 

125,000

 

125,000

 

Other long-term liabilities

 

10,505

 

5,474

 

 

 

 

 

 

 

Stockholders’ equity

 

 

 

 

 

Common stock

 

100

 

99

 

Additional paid-in capital

 

457,177

 

451,389

 

Deferred compensation

 

(527

)

(811

)

Treasury stock - at cost

 

(1,218

)

(1,218

)

Retained earnings deficit

 

(34,373

)

(101,507

)

Accumulated other comprehensive income

 

3,536

 

5,298

 

 

 

424,695

 

353,250

 

 

 

$

678,942

 

$

585,595

 

 



 

Axcelis Technologies, Inc.

Consolidated Statements of Operations

In thousands, except per share amounts

(Unaudited)

 

 

 

Three months ended
September 30,

 

Nine months ended
September 30,

 

 

 

2004

 

2003

 

2004

 

2003

 

Revenue

 

 

 

 

 

 

 

 

 

Systems

 

$

79,402

 

$

28,225

 

$

277,992

 

$

134,702

 

Services

 

44,827

 

30,782

 

125,097

 

91,381

 

Royalties

 

3,667

 

265

 

10,380

 

3,288

 

 

 

127,896

 

59,272

 

413,469

 

229,371

 

Cost of Revenue

 

73,817

 

45,108

 

240,814

 

157,493

 

 

 

 

 

 

 

 

 

 

 

Gross profit

 

54,079

 

14,164

 

172,655

 

71,878

 

 

 

 

 

 

 

 

 

 

 

Operating expenses

 

 

 

 

 

 

 

 

 

Research & development

 

16,645

 

16,273

 

48,009

 

48,376

 

Selling

 

12,248

 

11,983

 

36,683

 

35,590

 

General and administrative

 

11,943

 

10,841

 

34,645

 

30,383

 

Amortization of intangible assets

 

612

 

563

 

1,836

 

1,293

 

Restructuring charges

 

 

4,745

 

 

4,745

 

 

 

41,448

 

44,405

 

121,173

 

120,387

 

 

 

 

 

 

 

 

 

 

 

Income (loss) from operations

 

12,631

 

(30,241

)

51,482

 

(48,509

)

 

 

 

 

 

 

 

 

 

 

Other income (expense)

 

 

 

 

 

 

 

 

 

Equity income of Sumitomo Eaton Nova Corporation

 

9,065

 

41

 

22,212

 

4,534

 

Interest income

 

571

 

431

 

1,205

 

1,485

 

Interest expense

 

(1,643

)

(1,552

)

(5,017

)

(4,663

)

Other-net

 

(445

)

(267

)

(1,091

)

(945

)

 

 

7,548

 

(1,347

)

17,309

 

411

 

 

 

 

 

 

 

 

 

 

 

Income (loss) before income taxes

 

20,179

 

(31,588

)

68,791

 

(48,098

)

 

 

 

 

 

 

 

 

 

 

Income taxes

 

1,097

 

354

 

1,657

 

69,048

 

 

 

 

 

 

 

 

 

 

 

Net income (loss)

 

$

19,082

 

$

(31,942

)

$

67,134

 

$

(117,146

)

 

 

 

 

 

 

 

 

 

 

Basic net income (loss) per share

 

$

0.19

 

$

(0.32

)

$

0.68

 

$

(1.19

)

Diluted net income (loss) per share

 

$

0.19

 

$

(0.32

)

$

0.66

 

$

(1.19

)

 

 

 

 

 

 

 

 

 

 

Shares used in computing:

 

 

 

 

 

 

 

 

 

Basic net income (loss) per share

 

99,797

 

98,697

 

99,432

 

98,423

 

Diluted net income (loss) per share

 

101,007

 

98,697

 

101,271

 

98,423

 

 

Note: Income taxes for the nine months ended September 30, 2003 include a non-cash charge of $69.7 million ($0.70 per diluted

share) to reduce the carrying value of deferred tax assets to zero.